Cancer diagnostics company Nucleix is planning to scale up commercial activities in Europe for its bladder test Bladder EpiCheck. The Israeli firm told Medtech Insight it is currently in advanced negotiations with distributors to expand the test's commercial reach.
Israeli cancer diagnostics firm Nucleix is planning to scale up European commercial activities to expand the reach of its first product for bladder cancer, Bladder EpiCheck.
Bladder EpiCheck, is the first product to be launched by Nucleix. The urine test monitors patients for the recurrence of...
A government-backed program is working on improving the ability to run dementia clinical trials in the UK, and access to trials for participants.
After receiving FDA clearance for its Genio sleep apnea implant, Nyxoah plans a major US rollout despite a patent suit from rival Inspire Medical. Genio offers bilateral nerve stimulation as a CPAP alternative, with strong trial results.
Synchron is preparing a pilot study of its fully wireless, second-gen brain-computer interface after an ALS patient controlled an iPad solely by thought. If all goes as planned, Synchron’s BCI will move into pivotal trials in 2026.
